
51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
🏥 Healthcare
💰 $103.5M Post IPO equity on 2021-02
Biotechnology • Pharmaceuticals • Healthcare
LeonaBio is a clinical-stage biopharmaceutical company focused on developing novel small-molecule therapies for serious diseases with limited treatment options. Its lead candidates include lasofoxifene and brelgometon (ATH-1105), and the company conducts clinical trials to evaluate safety and efficacy as part of its mission to improve patient care. LeonaBio is active in medical affairs and patient outreach and has recently presented ATH-1105 at an ALS drug development summit, indicating involvement in neurodegenerative disease research.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 September 1
Senior Director guiding biostatistics for LeonaBio’s cancer and ALS therapeutics development. Leading clinical trial strategy, analyses, regulatory submissions, and CRO partnerships.
☕ Washington – Remote
💵 $270k - $290k / year
💰 $103.5M Post IPO equity on 2021-02
⏰ Full Time
🟠 Senior
👔 Director
👻 Ghost score 0%
🕒 September 1
Director leading drug safety and pharmacovigilance for LeonaBio’s oncology and ALS therapeutics. Building safety infrastructure, guiding regulatory submissions, and managing global risk surveillance.
☕ Washington – Remote
💵 $220k - $250k / year
💰 $103.5M Post IPO equity on 2021-02
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 0%
🕒 August 12
Regulatory strategy director advancing LeonaBio’s ALS and metastatic breast cancer therapeutics toward FDA and EU applications. Leading health authority interactions, submissions, and registration-enabling development strategies.
☕ Washington – Remote
💵 $220k - $260k / year
💰 $103.5M Post IPO equity on 2021-02
⏰ Full Time
🔴 Lead
🚔 Compliance
👻 Ghost score 0%
🕒 July 29
Leading medical affairs strategy execution for late-stage oncology asset development at LeonaBio. Overseeing scientific communication and collaboration across multiple teams to ensure success in product introduction.
☕ Washington – Remote
💵 $260k - $300k / year
💰 $103.5M Post IPO equity on 2021-02
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
👻 Ghost score 6%